Threonine ammonia-lyase (EC 4.3.1.19, systematic name L-threonine ammonia-lyase (2-oxobutanoate-forming), also commonly referred to as threonine deaminase or threonine dehydratase, is an
plants, though most research to date has focused on forms of the enzyme in bacteria. This enzyme was one of the first in which negative feedback inhibition by the end product of a metabolic pathway was directly observed and studied.[2] The enzyme serves as an excellent example of the regulatory strategies used in amino acid homeostasis
Key residues that interact with PLP within the active site. Generated from 1VE5.[6]
Mechanism
The mechanism of threonine ammonia-lyase is analogous to other deaminating PLP enzymes in its use of Schiff base
alpha carbon and subsequent dehydration (hence the common name threonine dehydratase), a new Schiff base is formed. This Schiff base is replaced by lysine attack, reforming the catalytically active PLP and releasing an initial alkene-containing product. This product tautomerizes, and after hydrolysis of the Schiff base, the final products are generated.[8][9] After the final alpha-ketobutyrate product is generated, isoleucine is synthesized by progressing through the intermediates alpha-acetohydroxybutyrate to alpha-beta-dihydroxy-beta-methylvalerate, then to alpha-keto-beta-methylvalerate.[10]
The mechanism of threonine ammonia-lyase.[8][9] PLP and lysine are shown in blue.
Regulation
Threonine ammonia-lyase has been shown to not follow
Michaelis-Menten kinetics, rather, it is subject to complex allosteric control.[11] The enzyme is inhibited by isoleucine, the product of the pathway it participates in, and is activated by valine, the product of a parallel pathway.[1] Thus, an increase in isoleucine concentration shuts off its production, and an increase in valine concentration diverts starting material (Hydroxyethyl-TPP) away from valine production. The enzyme has two binding sites for isoleucine; one has a high affinity for isoleucine and the other has a low affinity.[12] The binding of isoleucine to the high affinity site increases the binding affinity of the low affinity site, and enzyme deactivation occurs when isoleucine binds to the low affinity site. Valine promotes enzyme activity by competitively binding to the high affinity site, preventing isoleucine from having an inhibitory effect.[12]
The combination of these two feedback methods balances the concentration of BCAAs.
A diagram of the feedback regulatory pathways of threonine ammonia-lyase.[1]
Isoforms and other functions
Multiple forms of threonine ammonia-lyase have been observed in a variety of species of organism. In Escherichia coli, a system in which the enzyme has been studied extensively, two different forms of the enzyme are found. One is biosynthetic and resembles the enzyme characteristics presented here, while the other is degradative and functions to generate carbon fragments for energy production.[2] The pair of isoforms has also been observed in other bacteria. In many bacteria, the biodegradative isoform of the enzyme is expressed in anaerobic conditions and is promoted by cAMP and threonine, while the biosynthetic isoform is expressed in aerobic conditions.[13] This allows the bacterium to balance energy stores and inhibit energy-consuming synthetic pathways when energy is not abundant.
In plants, threonine ammonia-lyase is important in defense mechanisms against
herbivores and is upregulated in response to abiotic stress.[14] An adapted isoform of the enzyme with unique properties that deter herbivores is expressed in plant leaves. The catalytic domain of this isoform is extremely resistant to proteolysis, while the regulatory domain degrades readily, so upon ingestion by another organism, the threonine deamination capabilities of the enzyme go unchecked. This degrades threonine before the herbivore can absorb it, starving the herbivore of an essential amino acid.[15] Studies of threonine ammonia-lyase in plants have also offered new strategies in the development of GMOs with increased nutritional value by increasing essential amino acid content.[14]
Other more exotic forms of the enzyme have been found that are extremely small in size, but still retain all catalytic and regulatory functions.[4]
Evolution
There are five major fold types for PLP-dependent enzymes. Threonine ammonia-lyase is a member of the Fold Type II family, also known as the
pyruvate.[2] The regulatory domain of threonine ammonia-lyase is very similar to the regulatory domain of phosphoglycerate dehydrogenase.[4] All of these relationships demonstrate that threonine ammonia-lyase has close evolutionary ties to these enzymes. Due to the degree of conserved structure and sequence in enzymes that recognize amino acids, it is likely that the evolutionary diversity of these enzymes came about by the matching together of individual regulatory and catalytic domains in various ways.[1]
Relevance to humans
Threonine ammonia-lyase is not found in humans. Thus, this is one example of why humans cannot synthesize all 20
tumor suppressing agent for the previously described reasons, in that it deprives tumor cells of an essential amino acid and kills them,[16]
